According to FutureWise analysis the market for biologics contract development in 2023 was US$ 7.91 billion, and is expected to reach US$ 14.99 billion by 2031 at a CAGR of 8.30%. Biologics contract development involves the outsourcing of various processes related to the research, development, and optimization of biologics, which are complex therapeutic molecules derived from living organisms....